Published August 2007 | Version v1
Miscellaneous

Development of 188Re-HEDP as radiopharmaceutical for palliative bone pain

Description

Full text: The optimized condition for labeling HEDP with Re-188 was assessed by wet labeling. The mixture solution of 10 mg HEDP, 3 mg SnCl2.2H2O, 4 mg Gentisic acid and 50 ?g of NH4ReO4 was labeled with 3- 10 mCi ReO-4 at pH1 with heating temperature at 100 ?C for 15 minutes. After adjusting pH to 5-6 with 0.3 M NaOAc pH 8 and NaOH, radiochemical purity of the labeled product was checked by TLC. Labeling efficiency was high as 98.88%. The HEDP ligand was prepared in form of lyophilized kits then labeled and controlled for labeling efficiency. Labeling yield of labeled HEDP kits were more than 94% for 5 months storage. Biodistribution of 188Re-HEDP in rat measured in % injected dose/g of bone at time 2, 4 and 24 hours was 1.372%, 1.302% and 1.154%, respectively

Availability note (English)

Available in abstract form only, full text entered in this record. Available from Thailand Institute of Nuclear Technology, Bangkok (Thailand)

Additional details

Publishing Information

Imprint Pagination
10 p.
Report number
INIS-TH--170

Conference

Title
10. Conference on Nuclear Science and Technology
Dates
16-17 Aug 2007
Place
Bangkok (Thailand)

Optional Information

Secondary number(s)
NST--10-MS02